A study published today reveals more than 100,000 American youths are living with IBD, marking a significant increase since 2009, and pediatric IBD rates in the U.S. are among the highest globally. "These data are essential for healthcare professionals and policymakers to effectively manage pediatric IBD, make informed public health decisions, and ultimately improve outcomes for affected children and adolescents," said Andrés Hurtado-Lorenzo, PhD, Senior Vice President of Translational Research and IBD Ventures at the Crohn's & Colitis Foundation and study co-author. Read more: https://bit.ly/4fGr2Hy
关于我们
The Crohn's & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life for the millions of Americans living with IBD. Our work is dramatically accelerating the research process through our database and investment initiatives; we also provide extensive educational resources for patients and their families, medical professionals, and the public.
- 网站
-
https://www.crohnscolitisfoundation.org/
Crohn's & Colitis Foundation的外部链接
- 所属行业
- 非盈利组织
- 规模
- 201-500 人
- 总部
- New York
- 类型
- 非营利机构
- 创立
- 1967
- 领域
- Camp Oasis、Team Challenge、Take Steps和spin4 crohn's & colitis cures
地点
-
主要
获取路线
733 3rd Ave
Suite 510
US，New York，10017
Crohn's & Colitis Foundation员工
动态
-
Congratulations to Andres Hurtado-Lorenzo, PhD, Senior Vice President of Translational Research and IBD Ventures on co-authoring a book chapter "The Landscape of New Therapeutic Opportunities in IBD". This comprehensive overview, part of the upcoming "Emerging Therapeutic Targets and Drug Delivery Approaches in IBD" book, showcases cutting-edge strategies in IBD management.
Senior Vice President, Translational Research & IBD Ventures at the Crohn's & Colitis Foundation
???Thrilled to announce the release of our latest book chapter, which offers a comprehensive overview of "The Landscape of New Therapeutic Opportunities in IBD" You can read the full chapter here :?https://lnkd.in/g6GG3ZDV This is the first chapter in the forthcoming book “Emerging Therapeutic Targets and Drug Delivery Approaches in IBD,” expertly edited by Drs. Florin M. Selaru, MD, MBA and Diane Peters, DVM, PhD from The Johns Hopkins University. The book will be published as part of ELSEVIER's Advances in Pharmacology series on December 1, 2024. https://lnkd.in/g6GG3ZDV #IBD, #CrohnsDisease, #UlcerativeColitis, #Inflammation, #precisionmedicine, #personalizedmedice, #microbiome, #celltherapy, #Fibrostenosis, #pharmacology, #DrugDiscovery, #Biomarker, #crohnscolitisfoundation, #drugdelivery, #ibdventures
-
-
?? Happy World Toilet Day! Let’s take a moment to appreciate the throne that rules them all! ???? Crown your favorite public restroom in the comments and you could win a "Let’s Go There" t-shirt! ???Thank you to our sponsor, Lilly. #sponsored
-
-
?? Happy World Toilet Day! ?? Celebrate by downloading the We Can’t Wait app to easily find clean and accessible restrooms wherever you go. Let’s make sure we’re always prepared when nature calls! ??? https://bit.ly/3Q4K4fF #WorldToiletDay #WeCantWait Thank you to our sponsor, Lilly. #sponsored
-
-
Our Chief Scientific Officer, Dr. Alan Moss (second from left) spoke at the American Irish Medical Summit in Dublin on "Realizing the Potential of Patient Advocacy Organizations in Research Innovation." His presentation underscores the Foundation's commitment to drive groundbreaking research and improve the lives of those affected by IBD.
-
-
Kelly Issokson MS, RD, a Foundation Trustee and clinical dietitian at Cedars-Sinai, was recently interviewed by Medscape on the role of diet in managing Crohn's disease. In the interview, Issokson highlighted the importance of fiber in reducing flare-ups and improving patient well-being, emphasizing texture modifications for better tolerance. She also discussed the potential benefits of partial enteral nutrition in maintaining remission. Issokson contributed to the creation of GutFriendlyRecipes, a Foundation initiative featuring hundreds of dietitian-vetted recipes. https://wb.md/4fMk03u
-
This Crohn’s & Colitis Awareness Week, we’re recognizing IBD warriors who have the GUTS to go there and share their personal IBD journey. Share your story now until 11.23 or nominate someone for the 2nd annual “It Takes Guts” award! ?? The winner will be featured on the Foundation’s digital platforms and receive exclusive swag. https://bit.ly/3O3F6hX #CCAwarenessWeek #IBDVisible
-
-
If you are an IBD patient looking to enroll in a health insurance marketplace plan, the deadline for enrollment is January 15, 2025. To learn about your options in the health insurance marketplace, visit: https://bit.ly/3FMD7ZZ
-
-
The Crohn’s & Colitis Foundation has played a role in every major breakthrough in IBD thanks to the incredible support of our donors. Recently, our National Board of Trustees joined us to express our heartfelt gratitude to our generous supporters, whose transformative giving is honored through a new wall at our New York Headquarters. To all of our supporters— we are deeply grateful for all you do. Together, we are building a future free of IBD!
-
-
The Crohn’s & Colitis Foundation unveiled its research goals and priorities for the next five years. Dr Alan Moss, our chief scientific officer, explains what our new research priorities mean to people living with IBD. Check out the video here: https://bit.ly/48HGyjD
-